Heart Test Laboratories Inc. Common Stock (HSCS) - Total Assets
Based on the latest financial reports, Heart Test Laboratories Inc. Common Stock (HSCS) holds total assets worth $6.00 Million USD as of October 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Heart Test Laboratories Inc. Common Stoc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Heart Test Laboratories Inc. Common Stock - Total Assets Trend (2020–2025)
This chart illustrates how Heart Test Laboratories Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. See net assets of Heart Test Laboratories Inc. Common Stoc for net asset value and shareholders' equity analysis.
Heart Test Laboratories Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (April 2025)
Heart Test Laboratories Inc. Common Stock's total assets of $6.00 Million consist of 51.4% current assets and 48.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.0% |
| Accounts Receivable | $4.35K | 0.1% |
| Inventory | $650.27K | 15.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.62 Million | 38.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Heart Test Laboratories Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Heart Test Laboratories Inc. Common Stoc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Heart Test Laboratories Inc. Common Stock's current assets represent 51.4% of total assets in 2025, a decrease from 78.6% in 2020.
- Cash Position: Cash and equivalents constituted 26.0% of total assets in 2025, up from 25.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 38.3% of total assets.
Heart Test Laboratories Inc. Common Stock Competitors by Total Assets
Key competitors of Heart Test Laboratories Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
DexCom Inc
NASDAQ:DXCM
|
USA | $6.34 Billion |
|
Autobio Diagnostics Co Ltd
SHG:603658
|
China | CN¥11.73 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
ZYLOX-TONBRDG.MED.TECH.H1
F:818
|
Germany | €3.50 Billion |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$21.12 Million |
Heart Test Laboratories Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.42 | 1.72 | 1.47 |
| Quick Ratio | 2.00 | 1.52 | 0.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.23 Million | $2.39 Million | $524.28K |
Heart Test Laboratories Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Heart Test Laboratories Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.28 |
| Latest Market Cap to Assets Ratio | 2.10 |
| Asset Growth Rate (YoY) | -55.6% |
| Total Assets | $4.22 Million |
| Market Capitalization | $8.87 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Heart Test Laboratories Inc. Common Stock's assets at a significant premium (2.10x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Heart Test Laboratories Inc. Common Stock's assets decreased by 55.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Heart Test Laboratories Inc. Common Stock (2020–2025)
The table below shows the annual total assets of Heart Test Laboratories Inc. Common Stock from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-04-30 | $4.22 Million | -55.56% |
| 2024-04-30 | $9.50 Million | +189.09% |
| 2023-04-30 | $3.29 Million | +57.33% |
| 2022-04-30 | $2.09 Million | +8.41% |
| 2021-04-30 | $1.93 Million | -1.46% |
| 2020-04-30 | $1.96 Million | -- |
About Heart Test Laboratories Inc. Common Stock
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting… Read more